Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ)
CNY 7.0
(-2.51%)
CNY 7.0
(-2.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 49.2 Million CNY | -33.79% |
| 2022 | 74.32 Million CNY | -55.36% |
| 2021 | 166.5 Million CNY | -41.56% |
| 2020 | 284.93 Million CNY | 81.45% |
| 2019 | 157.02 Million CNY | 86.76% |
| 2018 | 84.08 Million CNY | -14.39% |
| 2017 | 98.21 Million CNY | 40.84% |
| 2016 | 69.73 Million CNY | 10.65% |
| 2015 | 63.02 Million CNY | -41.39% |
| 2014 | 107.53 Million CNY | -3.61% |
| 2013 | 111.55 Million CNY | 29.1% |
| 2012 | 86.4 Million CNY | -45.53% |
| 2011 | 158.64 Million CNY | 4.38% |
| 2010 | 151.98 Million CNY | 25.56% |
| 2009 | 121.04 Million CNY | 63.47% |
| 2008 | 74.04 Million CNY | 16.4% |
| 2007 | 63.61 Million CNY | 93.65% |
| 2006 | 32.84 Million CNY | 53.62% |
| 2005 | 21.38 Million CNY | -16.71% |
| 2004 | 25.67 Million CNY | 26.88% |
| 2003 | 20.23 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 8 Million CNY | -9.74% |
| 2024 Q2 | 8.86 Million CNY | -69.26% |
| 2024 Q1 | 28.83 Million CNY | -48.66% |
| 2023 Q1 | 27.33 Million CNY | 141.93% |
| 2023 Q2 | 4.25 Million CNY | -84.44% |
| 2023 Q3 | -38.55 Million CNY | -1006.63% |
| 2023 Q4 | 56.17 Million CNY | 245.7% |
| 2023 FY | 49.2 Million CNY | -33.79% |
| 2022 Q2 | 33.3 Million CNY | 34.38% |
| 2022 FY | 74.32 Million CNY | -55.36% |
| 2022 Q3 | 90.2 Million CNY | 170.82% |
| 2022 Q4 | -65.2 Million CNY | -172.28% |
| 2022 Q1 | 24.78 Million CNY | 74.02% |
| 2021 FY | 166.5 Million CNY | -41.56% |
| 2021 Q1 | 27.57 Million CNY | -83.2% |
| 2021 Q2 | 84.68 Million CNY | 207.13% |
| 2021 Q3 | 40.01 Million CNY | -52.75% |
| 2021 Q4 | 14.24 Million CNY | -64.4% |
| 2020 Q3 | 206.58 Thousand CNY | -99.72% |
| 2020 Q4 | 164.15 Million CNY | 79361.37% |
| 2020 Q1 | 47.8 Million CNY | -41.51% |
| 2020 Q2 | 72.76 Million CNY | 52.22% |
| 2020 FY | 284.93 Million CNY | 81.45% |
| 2019 Q4 | 81.72 Million CNY | 264.93% |
| 2019 Q1 | 10.84 Million CNY | -66.9% |
| 2019 Q2 | 42.05 Million CNY | 287.73% |
| 2019 Q3 | 22.39 Million CNY | -46.75% |
| 2019 FY | 157.02 Million CNY | 86.76% |
| 2018 Q3 | 16.85 Million CNY | -33.22% |
| 2018 Q4 | 32.76 Million CNY | 94.46% |
| 2018 FY | 84.08 Million CNY | -14.39% |
| 2018 Q1 | 9.23 Million CNY | -75.5% |
| 2018 Q2 | 25.23 Million CNY | 173.36% |
| 2017 Q3 | 30.8 Million CNY | 38.46% |
| 2017 Q2 | 22.24 Million CNY | 197.29% |
| 2017 Q1 | 7.48 Million CNY | -42.77% |
| 2017 FY | 98.21 Million CNY | 40.84% |
| 2017 Q4 | 37.67 Million CNY | 22.32% |
| 2016 Q1 | 9.5 Million CNY | 225.99% |
| 2016 FY | 69.73 Million CNY | 10.65% |
| 2016 Q4 | 13.07 Million CNY | -28.72% |
| 2016 Q3 | 18.34 Million CNY | -36.33% |
| 2016 Q2 | 28.81 Million CNY | 203.27% |
| 2015 Q4 | -7.54 Million CNY | -133.58% |
| 2015 Q1 | 10.32 Million CNY | -66.29% |
| 2015 FY | 63.02 Million CNY | -41.39% |
| 2015 Q2 | 37.79 Million CNY | 266.17% |
| 2015 Q3 | 22.45 Million CNY | -40.58% |
| 2014 FY | 107.53 Million CNY | -3.61% |
| 2014 Q3 | 22.76 Million CNY | -32.53% |
| 2014 Q1 | 20.4 Million CNY | -46.95% |
| 2014 Q4 | 30.61 Million CNY | 34.46% |
| 2014 Q2 | 33.74 Million CNY | 65.41% |
| 2013 Q3 | 22.15 Million CNY | -38.99% |
| 2013 Q1 | 14.63 Million CNY | -44.75% |
| 2013 Q2 | 36.3 Million CNY | 148.05% |
| 2013 Q4 | 38.45 Million CNY | 73.59% |
| 2013 FY | 111.55 Million CNY | 29.1% |
| 2012 FY | 86.4 Million CNY | -45.53% |
| 2012 Q3 | 16.15 Million CNY | -39.95% |
| 2012 Q2 | 26.89 Million CNY | 59.51% |
| 2012 Q1 | 16.86 Million CNY | -45.66% |
| 2012 Q4 | 26.49 Million CNY | 64.02% |
| 2011 Q1 | 30.51 Million CNY | -33.56% |
| 2011 FY | 158.64 Million CNY | 4.38% |
| 2011 Q2 | 56.33 Million CNY | 84.66% |
| 2011 Q4 | 31.03 Million CNY | -23.86% |
| 2011 Q3 | 40.76 Million CNY | -27.65% |
| 2010 Q2 | 40.2 Million CNY | 67.68% |
| 2010 Q4 | 45.92 Million CNY | 9.64% |
| 2010 Q1 | 23.97 Million CNY | -47.63% |
| 2010 Q3 | 41.88 Million CNY | 4.19% |
| 2010 FY | 151.98 Million CNY | 25.56% |
| 2009 FY | 121.04 Million CNY | 63.47% |
| 2009 Q4 | 45.77 Million CNY | 33.86% |
| 2009 Q3 | 34.19 Million CNY | 8.5% |
| 2009 Q2 | 31.51 Million CNY | 229.78% |
| 2009 Q1 | 9.55 Million CNY | -28.55% |
| 2008 FY | 74.04 Million CNY | 16.4% |
| 2008 Q3 | 24.73 Million CNY | -3.42% |
| 2008 Q1 | 10.32 Million CNY | -48.94% |
| 2008 Q2 | 25.6 Million CNY | 147.92% |
| 2008 Q4 | 13.37 Million CNY | -45.92% |
| 2007 Q2 | 20.86 Million CNY | 197.51% |
| 2007 Q4 | 20.22 Million CNY | 30.44% |
| 2007 Q1 | 7.01 Million CNY | -32.8% |
| 2007 FY | 63.61 Million CNY | 93.65% |
| 2007 Q3 | 15.5 Million CNY | -25.68% |
| 2006 Q4 | 10.43 Million CNY | 3.51% |
| 2006 Q3 | 10.08 Million CNY | -6.24% |
| 2006 Q2 | 10.75 Million CNY | 582.29% |
| 2006 Q1 | 1.57 Million CNY | -76.25% |
| 2006 FY | 32.84 Million CNY | 53.62% |
| 2005 Q3 | -1.57 Million CNY | 0.0% |
| 2005 Q4 | 6.63 Million CNY | 522.54% |
| 2005 FY | 21.38 Million CNY | -16.71% |
| 2004 FY | 25.67 Million CNY | 26.88% |
| 2003 FY | 20.23 Million CNY | 0.0% |